Status:
COMPLETED
Comparison of Intranasal Oxytocin Effects Using Co-administration With a Vasoconstrictor
Lead Sponsor:
University of Electronic Science and Technology of China
Conditions:
Healthy
Eligibility:
MALE
18-30 years
Phase:
NA
Brief Summary
This study aims to dissociate direct from indirectly mediated effects of intranasal oxytocin administration by using treatment with or without prior intranasal administration of a vasoconstrictor to r...
Eligibility Criteria
Inclusion
- Healthy subjects without past or current psychiatric or neurological disorders
Exclusion
- history of head injury
- medical or psychiatric illness.
Key Trial Info
Start Date :
March 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2021
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT04134663
Start Date
March 2 2019
End Date
July 20 2021
Last Update
February 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
school of life science and technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China, 610054